When the Endocrine Society launched the *Journal of the Endocrine Society* (JES) at the start of 2017, we envisaged a broad-ranging open-access journal that would employ simplified decision-making to enable rapid publication of important results across the full range of basic, translational, and clinical endocrine topics. Three and a half years later, that formula is unchanged, and the ambition has been largely realized, with over 550 articles now published, many of them well cited. Usage has grown impressively, with global downloads more than doubling in 2019 over the previous year, to 283 000. The number of submissions continues on an upward trajectory. All accepted articles are deposited in PubMed Central immediately upon publication, and articles are tracked by major indexers, including SCOPUS and the Emerging Sources Citation Index in Clarivate's Web of Science. As a new journal, JES must accumulate data to be assigned an impact factor in Clarivate's Web of Science, but the Endocrine Society's internal calculations would be in the 2.0--2.4 range, an impressive result for a journal in only its fourth year of publication, with only three years of citation activity.

In an effort to broaden the usefulness of JES to endocrine fellows and practicing clinicians, we are now introducing a new venue for teaching and learning: *Expert Endocrine Consult*.

*Expert Endocrine Consult* articles are intended to be more substantial than a typical case report. We envisage these to resemble typical endocrine attending rounds, case conferences, or discussions at meet-the-professor sessions. They will use common clinical scenarios as the basis for discussion of differential diagnosis, pathophysiology, and approach to management and treatment. They will reference pertinent clinical practice guidelines, treatment recommendations, and other recent literature, thus becoming an invaluable learning resource for clinicians worldwide. Further details are provided in Author Guidelines at <https://academic.oup.com/jes/pages/Author_Guidelines>.

The JES submission platform at <https://www.editorialmanager.com/JS> is now ready to receive *Expert Endocrine Consult* submissions, as well as all our other types of research and commentary. These submissions would be an excellent venue for joint authorship by trainees and attendings or physician groups who regularly hold these types of conferences. I and my associate editors look forward to receiving your best examples of learning from common or rare patient presentations.
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